In fact, in pancreatic tumor cells, the ERK pathway which is continuously activated by KRAS mutations, confers resistance against apoptosis and regulates the progression of these cells in the cell cycle [66]. The gene discussed is KRAS; the disease is pancreatic neoplasm.